WHO WE ARE
As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Code of conduct Global presence
OUR FOCUS
Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

UPDATES TO THE EXECUTIVE LEADERSHIP TEAM

Corporate News and Press Releases

Date26.08.2026

Annika Petersen will join Pharmacosmos on 1 November 2026 as Executive Vice President, Product Supply.

Annika brings 20 years of experience from the pharmaceutical industry and extensive technical and leadership expertise across manufacturing, supply chain, quality and engineering. Throughout her career, she has held several senior leadership positions, including at Fujifilm Diosynth Biotechnologies and Biogen. Most recently, she served as Managing Director and CEO of Syntese A/S, part of the Ferring Group.

Tobias S. Christensen, President and CEO, says:

I am very pleased to welcome Annika to our Executive Leadership Team. She brings deep product supply expertise, a strong international perspective and an impressive track record of leading complex pharmaceutical operations. Her capabilities will further strengthen our organisation as we continue to execute our ambitious strategy. I look forward to working closely with her.

Go to News & Press